Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosytems, SurroMed Receive $8M NIST Grant

SAN FRANCISCO, Oct. 17 – Applied Biosytems and SurroMed jointly received a three-year $8 million grant from the National Institute of Standards and Technology Advanced Technology Program, the companies announced Wednesday.

The grant is for the development of Mountain View, Calif.-based SurroMed's nanoscale technology and Foster City, Calif.-based Applied Biosystems' multiplexing chemistry capabilities for DNA analysis. $3.7 million is slated for SurroMed and $4.3 million for Applied Biosystems, according to the companies.

“We are pleased to receive the NIST-ATP grant to develop our novel technology with the chemistry development capabilities of Applied Biosystems,” Gordon Ringold, CEO of SurroMed, said in a statement. “We are developing the technology for use in our discovery programs, and the collaboration with Applied Biosystems reflects our strategy to partner certain applications with leading companies.”

Applied Biosytems is a unit of Applera.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more